GREENWICH LIFESCIENCES INC
GLSI · NASDAQ
Updated at 2026-10-14 09:06:44
- Today's High
- $17.75
- Today’s Low
- $14.06
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $16.45
- Previous Close
- $17.77
- Volume
- 163.23K
- Market Cap
- $260.83M
- P/E Ratio
- --
- EPS
- $-1.53
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- BUILDING 14, STAFFORD, TX, UNITED STATES, 77477
- Country
- US
- Listing Date
- 2020-09-25
- Fiscal Year End
- December
- Shares Outstanding
- 14.68M
- CIK
- 0001799788
- Website
- greenwichlifesciences.com
Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development of new cancer immunotherapies for breast and other HER2 / neu-expressing cancers. The company is headquartered in Stafford, Texas.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$3.55K
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$4.02M
2026-03-31
$5.72M
2025-12-31
$7.94M
2025-09-30
$4.17M
Net Income
2026-06-30
-$3.94M
2026-03-31
-$5.65M
2025-12-31
-$7.92M
2025-09-30
-$4.15M
Net Profit Margin
2026-06-30
--
2026-03-31
-158.99K%
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-0.27
2026-03-31
$-0.39
2025-12-31
$-0.58
2025-09-30
$-0.30
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$3.94M
2026-03-31
-$5.65M
2025-12-31
-$7.94M
2025-09-30
-$4.15M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $3.55K | $0 | $0 |
| Operating Expenses | $4.02M | $5.72M | $7.94M | $4.17M |
| Net Income | -$3.94M | -$5.65M | -$7.92M | -$4.15M |
| Net Profit Margin | -- | -158.99K% | -- | -- |
| Earnings Per Share | $-0.27 | $-0.39 | $-0.58 | $-0.30 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$3.94M | -$5.65M | -$7.94M | -$4.15M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.